• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Hein Heidbuchel, Peter Verhamme, +7 authors Paulus Kirchhof
  • Medicine
  • Europace : European pacing, arrhythmias, and…
  • 2015 (First Publication: 1 October 2015)
  • The current manuscript is an update of the original Practical Guide, published in June 2013[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart Rhythm AssociationContinue Reading
  • Hein Heidbuchel, Peter Verhamme, +6 authors Paulus Kirchhof
  • Medicine
  • Europace : European pacing, arrhythmias, and…
  • 2013 (First Publication: 1 May 2013)
  • New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and patients will have toContinue Reading
  • Jonathan Emberson, Kennedy R. Lees, +27 authors Werner Hacke
  • Medicine
  • The Lancet
  • 2014 (First Publication: 28 November 2014)
  • BACKGROUND Alteplase is effective for treatment of acute ischaemic stroke but debate continues about its use after longer times since stroke onset, in older patients, and among patients who have hadContinue Reading
  • Werner Hacke, Stefan Schwab, Michelle Horn, Matthias Spranger, Michael A. De Georgia, Rudiger von Kummer
  • Medicine
  • Archives of neurology
  • 1996 (First Publication: 1 April 1996)
  • BACKGROUND Although the clinical features of space-occupying ischemic stroke are well known, there are limited prospective data on the clinical course of complete middle cerebral artery territoryContinue Reading
  • Nils Gunnar Wahlgren, Niaz Ahmed, Antoni Davalos, Werner Hacke, for the Sits investigators
  • Medicine
  • The Lancet
  • 2008 (First Publication: 1 October 2008)
  • BACKGROUND Intravenous alteplase is approved for use within 3 h of ischaemic stroke onset, although a meta-analysis of randomised controlled trials suggests treatment benefit up to 4.5 h. We comparedContinue Reading